Citation: Ms. Atta et al., CHARACTERIZATION OF A NOVEL HUMAN-ANTIBODY XENOREACTIVE WITH FIBRONECTIN, Clinical immunology and immunopathology, 80(3), 1996, pp. 336-336
Authors:
ALAALDEEN DAA
WESTPHAL AH
DEKOK A
WESTON V
ATTA MS
BALDWIN TJ
BARTLEY J
BORRIELLO SP
Citation: Daa. Alaaldeen et al., CLONING, SEQUENCING, CHARACTERIZATION AND IMPLICATIONS FOR VACCINE DESIGN OF THE NOVEL DIHYDROLIPOYL ACETYLTRANSFERASE OF NEISSERIA-MENINGITIDIS, Journal of Medical Microbiology, 45(6), 1996, pp. 419-432
Citation: Ms. Atta et al., ENHANCED EXPRESSION OF MHC CLASS-I MOLECULES ON CULTURED HUMAN THYROID FOLLICULAR CELLS INFECTED WITH REOVIRUS THROUGH INDUCTION OF TYPE-1 INTERFERONS, Clinical and experimental immunology, 101(1), 1995, pp. 121-126
Authors:
ATTA MS
LIM KL
ALAALDEEN DA
POWELL RJ
TODD I
Citation: Ms. Atta et al., INVESTIGATION OF THE PREVALENCE AND CLINICAL ASSOCIATIONS OF ANTIBODIES TO HUMAN FIBRONECTIN IN SYSTEMIC LUPUS-ERYTHEMATOSUS, Annals of the Rheumatic Diseases, 54(2), 1995, pp. 117-124
Citation: Ms. Atta et al., HUMAN ANTIFIBRONECTIN ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS - OCCURRENCE AND ANTIGENIC SPECIFICITY, Clinical and experimental immunology, 96(1), 1994, pp. 20-25
Citation: Ms. Atta et al., THE INFLUENCE OF ANTIFIBRONECTIN ANTIBODIES ON INTERACTIONS INVOLVINGEXTRACELLULAR-MATRIX COMPONENTS AND CELLS - A POSSIBLE PATHOGENIC MECHANISM, Clinical and experimental immunology, 96(1), 1994, pp. 26-30